Viruses vs. superbugs: new hope for cystic fibrosis patients
NCT ID NCT07280598
First seen Jan 05, 2026 · Last updated May 16, 2026 · Updated 25 times
Summary
This early-stage study tests whether adding special viruses (called phages) to standard antibiotics can safely treat hard-to-kill lung infections in adults with cystic fibrosis. About 30 participants will receive a 7-day course of both treatments. The main goal is to check safety, but researchers will also measure changes in lung function and infection levels to guide future studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for E COLI INFECTIONS are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.